These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22123293)

  • 1. Developmental pathways in breast cancer and breast tumor-initiating cells: therapeutic implications.
    Izrailit J; Reedijk M
    Cancer Lett; 2012 Apr; 317(2):115-26. PubMed ID: 22123293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Signal pathways in breast cancer stem cells and the targeted stem cell therapy].
    Ma Y; Wang HX
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):881-5. PubMed ID: 21223793
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.
    Grudzien P; Lo S; Albain KS; Robinson P; Rajan P; Strack PR; Golde TE; Miele L; Foreman KE
    Anticancer Res; 2010 Oct; 30(10):3853-67. PubMed ID: 21036696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer stem cells: a novel therapeutic target.
    Gangopadhyay S; Nandy A; Hor P; Mukhopadhyay A
    Clin Breast Cancer; 2013 Feb; 13(1):7-15. PubMed ID: 23127340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hedgehog signalling pathway as a therapeutic target in early breast cancer development.
    O'Toole SA; Swarbrick A; Sutherland RL
    Expert Opin Ther Targets; 2009 Sep; 13(9):1095-103. PubMed ID: 19659449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cells - A therapeutic target?
    Maitland NJ; Collins AT
    Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the cell of origin in breast cancer and breast cancer stem cells.
    Lindeman GJ; Visvader JE
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):89-97. PubMed ID: 20565420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hedgehog pathway as a drug target in cancer therapy.
    Lauth M; Toftgård R
    Curr Opin Investig Drugs; 2007 Jun; 8(6):457-61. PubMed ID: 17621875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in targeting the Hedgehog signaling pathway in cancer therapy.
    Kiesslich T; Neureiter D
    Expert Opin Ther Targets; 2012 Feb; 16(2):151-6. PubMed ID: 22233124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology of breast cancer stem cells: potential clinical applications.
    Nguyen NP; Almeida FS; Chi A; Nguyen LM; Cohen D; Karlsson U; Vinh-Hung V
    Cancer Treat Rev; 2010 Oct; 36(6):485-91. PubMed ID: 20231058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of microRNAs in breast cancer.
    Adams BD; Guttilla IK; White BA
    Semin Reprod Med; 2008 Nov; 26(6):522-36. PubMed ID: 18951334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of stemness-related signaling pathways in breast cancer response to therapy.
    Angeloni V; Tiberio P; Appierto V; Daidone MG
    Semin Cancer Biol; 2015 Apr; 31():43-51. PubMed ID: 25153354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method.
    Kai M; Onishi H; Souzaki M; Tanaka H; Kubo M; Tanaka M; Katano M
    Cancer Sci; 2011 Dec; 102(12):2132-8. PubMed ID: 21838786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental signaling pathways in brain tumor-derived stem-like cells.
    Clark PA; Treisman DM; Ebben J; Kuo JS
    Dev Dyn; 2007 Dec; 236(12):3297-308. PubMed ID: 18000980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging targets for hematological malignancies.
    Cilloni D; Frassoni F; Saglio G
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):548-58. PubMed ID: 20812146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies.
    Vera-Ramirez L; Sanchez-Rovira P; Ramirez-Tortosa MC; Ramirez-Tortosa CL; Granados-Principal S; Lorente JA; Quiles JL
    Crit Rev Oncol Hematol; 2011 Dec; 80(3):347-68. PubMed ID: 21288735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cell: target for anti-cancer therapy.
    Tang C; Ang BT; Pervaiz S
    FASEB J; 2007 Dec; 21(14):3777-85. PubMed ID: 17625071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological therapy of breast cancer: recent clinical applications.
    Baar J
    Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel targeted agents for the treatment of advanced breast cancer.
    de la Vega M; Díaz-Cantón E; Alvarez RH
    Future Med Chem; 2012 May; 4(7):893-914. PubMed ID: 22571614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer.
    Stratford AL; Reipas K; Maxwell C; Dunn SE
    Expert Rev Mol Med; 2010 Jul; 12():e22. PubMed ID: 20653987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.